These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 9622055)
21. Isolation and characterization of a novel, transforming allele of the c-Cbl proto-oncogene from a murine macrophage cell line. Bisson SA; Ujack EE; Robbins SM Oncogene; 2002 May; 21(23):3677-87. PubMed ID: 12032836 [TBL] [Abstract][Full Text] [Related]
22. A conserved DpYR motif in the juxtamembrane domain of the Met receptor family forms an atypical c-Cbl/Cbl-b tyrosine kinase binding domain binding site required for suppression of oncogenic activation. Peschard P; Ishiyama N; Lin T; Lipkowitz S; Park M J Biol Chem; 2004 Jul; 279(28):29565-71. PubMed ID: 15123609 [TBL] [Abstract][Full Text] [Related]
23. Leucine zipper-mediated homodimerization of the adaptor protein c-Cbl. A role in c-Cbl's tyrosine phosphorylation and its association with epidermal growth factor receptor. Bartkiewicz M; Houghton A; Baron R J Biol Chem; 1999 Oct; 274(43):30887-95. PubMed ID: 10521482 [TBL] [Abstract][Full Text] [Related]
24. Structure of the amino-terminal domain of Cbl complexed to its binding site on ZAP-70 kinase. Meng W; Sawasdikosol S; Burakoff SJ; Eck MJ Nature; 1999 Mar; 398(6722):84-90. PubMed ID: 10078535 [TBL] [Abstract][Full Text] [Related]
25. Similarity of sli-1, a regulator of vulval development in C. elegans, to the mammalian proto-oncogene c-cbl. Yoon CH; Lee J; Jongeward GD; Sternberg PW Science; 1995 Aug; 269(5227):1102-5. PubMed ID: 7652556 [TBL] [Abstract][Full Text] [Related]
26. Inhibition of signaling through the B cell antigen receptor by the protooncogene product, c-Cbl, requires Syk tyrosine 317 and the c-Cbl phosphotyrosine-binding domain. Yankee TM; Keshvara LM; Sawasdikosol S; Harrison ML; Geahlen RL J Immunol; 1999 Dec; 163(11):5827-35. PubMed ID: 10570266 [TBL] [Abstract][Full Text] [Related]
27. Cbl: complex formation and functional implications. Liu YC; Altman A Cell Signal; 1998 Jun; 10(6):377-85. PubMed ID: 9720760 [TBL] [Abstract][Full Text] [Related]
28. Tyrosine phosphorylation and complex formation of Cbl-b upon T cell receptor stimulation. Elly C; Witte S; Zhang Z; Rosnet O; Lipkowitz S; Altman A; Liu YC Oncogene; 1999 Feb; 18(5):1147-56. PubMed ID: 10022120 [TBL] [Abstract][Full Text] [Related]
29. The involvement of the proto-oncogene p120 c-Cbl and ZAP-70 in CD2-mediated T cell activation. Lin H; Martelli MP; Bierer BE Int Immunol; 2001 Jan; 13(1):13-22. PubMed ID: 11133830 [TBL] [Abstract][Full Text] [Related]
30. c-Cbl: a regulator of T cell receptor-mediated signalling. Thien CB; Langdon WY Immunol Cell Biol; 1998 Oct; 76(5):473-82. PubMed ID: 9797470 [TBL] [Abstract][Full Text] [Related]
31. RING finger mutations that abolish c-Cbl-directed polyubiquitination and downregulation of the EGF receptor are insufficient for cell transformation. Thien CB; Walker F; Langdon WY Mol Cell; 2001 Feb; 7(2):355-65. PubMed ID: 11239464 [TBL] [Abstract][Full Text] [Related]
32. A novel phosphotyrosine-binding domain in the N-terminal transforming region of Cbl interacts directly and selectively with ZAP-70 in T cells. Lupher ML; Reedquist KA; Miyake S; Langdon WY; Band H J Biol Chem; 1996 Sep; 271(39):24063-8. PubMed ID: 8798643 [TBL] [Abstract][Full Text] [Related]
33. Formation of Shc/Grb2- and Crk adaptor complexes containing tyrosine phosphorylated Cbl upon stimulation of the B-cell antigen receptor. Smit L; van der Horst G; Borst J Oncogene; 1996 Jul; 13(2):381-9. PubMed ID: 8710377 [TBL] [Abstract][Full Text] [Related]
34. cbl-3: a new mammalian cbl family protein. Keane MM; Ettenberg SA; Nau MM; Banerjee P; Cuello M; Penninger J; Lipkowitz S Oncogene; 1999 Jun; 18(22):3365-75. PubMed ID: 10362357 [TBL] [Abstract][Full Text] [Related]
35. A direct interaction between the adaptor protein Cbl-b and the kinase zap-70 induces a positive signal in T cells. Zhang Z; Elly C; Qiu L; Altman A; Liu YC Curr Biol; 1999 Feb; 9(4):203-6. PubMed ID: 10074432 [TBL] [Abstract][Full Text] [Related]
36. Proto-oncogene products Vav and c-Cbl are involved in the signal transduction through Grb2/Ash in hematopoietic cells. Hanazono Y; Odai H; Sasaki K; Iwamatsu A; Yazaki Y; Hirai H Acta Haematol; 1996; 95(3-4):236-42. PubMed ID: 8677749 [TBL] [Abstract][Full Text] [Related]
37. Enhancement of fcgamma receptor-mediated phagocytosis by transforming mutants of Cbl. Sato N; Kim MK; Schreiber AD J Immunol; 1999 Dec; 163(11):6123-31. PubMed ID: 10570302 [TBL] [Abstract][Full Text] [Related]
38. Identification of a novel proline-arginine motif involved in CIN85-dependent clustering of Cbl and down-regulation of epidermal growth factor receptors. Kowanetz K; Szymkiewicz I; Haglund K; Kowanetz M; Husnjak K; Taylor JD; Soubeyran P; Engstrom U; Ladbury JE; Dikic I J Biol Chem; 2003 Oct; 278(41):39735-46. PubMed ID: 12874286 [TBL] [Abstract][Full Text] [Related]
39. Oncogenic forms of Cbl abrogate the anchorage requirement but not the growth factor requirement for proliferation. Ojaniemi M; Langdon WY; Vuori K Oncogene; 1998 Jun; 16(24):3159-67. PubMed ID: 9671395 [TBL] [Abstract][Full Text] [Related]
40. Tumour induction by activated abl involves tyrosine phosphorylation of the product of the cbl oncogene. Andoniou CE; Thien CB; Langdon WY EMBO J; 1994 Oct; 13(19):4515-23. PubMed ID: 7925293 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]